Our data clearly demonstrate that IM reduces transcriptional levels of ID1 with further reductions in the presence of LDN and DOR in both CML CD34+ and CML-iPSCs. The gene discussed is ID1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.